Study summary · research use only
The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
In this human cell study, the authors investigated whether the anticancer peptide PNC-27 (an HDM-2-binding p53 peptide attached to a membrane-penetrating peptide) induces pore formation in cancer cells. They prepared PNC-27 with a green fluorescent label on its amino terminus and a red label on its carboxyl terminus and treated MCF-7 breast cancer cells and untransformed MCF-10-2A breast epithelial cells. The abstract reports that at 30 min there was significant punctate combined yellow fluorescence, indicative of intact peptide, in the cancer cell membrane, increasing during lysis, while untransformed cells showed initial uniform yellow membrane fluorescence that subsequently disappeared and remained viable. The authors conclude PNC-27 induces cancer cell membrane lysis as the whole peptide, via intramembrane targets present in MCF-7 but not untransformed cells.
Abstract
PNC-27, a peptide that contains an HDM-2-binding domain from p53 attached to a membrane-penetrating peptide on its carboxyl terminal end, is cytotoxic to cancer, but not normal, cells. It forms transmembrane pores in the cancer cell membrane. Our purpose is to determine if the whole peptide or critical fragments induce pore formation in cancer cells. We have prepared PNC-27 with a green fluorescent label on its amino terminus and a red fluorescent label on its carboxyl terminus and treated MCF-7 breast cancer cells and untransformed MCF-10-2A breast epithelial cells with this double-labeled peptide to determine if combined yellow fluorescence occurs in the membrane of the cancer cells during cancer cell killing. At 30 min, there is significant combined punctate yellow fluorescence, indicative of intact peptide, in the cell membrane of cancer cells that increases during cancer cell lysis. MCF-10-2A cells show initial (30 min) uniform combined yellow membrane fluorescence that subsequently disappears. Unlike the cancer cells, these untransformed cells remain viable. PNC-27 induces cancer cell membrane lysis by acting as the whole peptide, not fragments. The punctate yellow fluorescence is due to interaction of PNC-27 with intramembrane targets of MCF-7 cells that do not exist in the membrane of the untransformed cell line. This interaction increases the lifetime of PNC-27. Absence of these targets in the membranes of the untransformed MCF-10-2A cells results in initial uniform fluorescence of the double-labeled peptide in their membranes after which the peptide is degraded.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.